Additional file 1 of Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study
OA: green
CC0
AI-generated summary
This supplementary material presents data related to the efficacy and safety of eliapixant in treating endometriosis-associated pelvic pain, as observed in the Phase 2b SCHUMANN study.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Supplementary Material 1
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (36)
- Effect of A-317491 delivered by glycolipid-like polymer micelles on endometriosis pain via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis-associated nerve fibers, peritoneal fluid cytokine concentrations, and pain in endometriotic lesions from different locations via openalex
- Endometriosis: Epidemiology, Diagnosis and Clinical Management via openalex
- Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members via openalex
- Hyperinnervation in intestinal deep infiltrating endometriosis via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Inflammation and nerve fiber interaction in endometriotic pain via openalex
- Natural hair color and the incidence of endometriosis via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- Patterns of missing data in the use of the endometriosis symptom diary via openalex
- Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis? via openalex
- Research Priorities for Endometriosis via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- The direct and indirect costs associated with endometriosis: a systematic literature review via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
- World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: II. Clinical and covariate phenotype data collection in endometriosis research via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
Source provenance
- openalex
- last seen: 2026-05-11T08:54:56.748115+00:00
License: CC0
· commercial use OK